| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $719.9M | -1.7% |
| Cost of Revenue | $363.8M | +1.6% |
| Gross Profit | $356.1M | -4.8% |
| R&D Expense | $85.8M | +16.1% |
| SG&A Expense | $85.9M | +51.5% |
| Operating Income | $140.4M | -31.7% |
| Pre-tax Income | $123.6M | -34.9% |
| Income Tax | $25.5M | -14.0% |
| Net Income | $98.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $170.2M | +12.2% |
| Short-term Investments | $112.6M | +60.8% |
| Accounts Receivable | $143.6M | +5.3% |
| Inventory | $176.9M | +15.1% |
| Current Assets | $636.0M | +19.1% |
| Total Assets | $1.63B | +3.3% |
| Current Liabilities | $158.2M | -9.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $156.1M | -26.8% |
| Capital Expenditures | $34.9M | -15.0% |
| Investing Cash Flow | -$70.3M | +43.7% |
| Financing Cash Flow | -$67.4M | +16.7% |
| Free Cash Flow | $121.2M | -29.7% |
| -38.5% |
| EPS (Basic) | $2.10 | -36.2% |
| EPS (Diluted) | $2.03 | -33.7% |
| Long-term Debt |
| $619.7M |
| +1.0% |
| Total Liabilities | $840.5M | -0.6% |
| Stockholders' Equity | $788.8M | +7.7% |